← Leaderboards
Richard L Carpenter
Indiana University Indianapolis
$864,444
Attributed
$864,444
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $378.4K · FY2017–25$500K$375K$250K$125K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$864,444 · 2
By mechanism
K22$486,000 · 1
R01$378,444 · 1
Top collaborators
No co-investigators on record.
Most similar at Indiana University Indianapolis
Same institution · by research overlap
- Elizabeth S. Yeh$3,779,725
- Todd C. Skaar$14,016,309
Others in their field
Other Emerging Leaders on “Patient-Focused Outcomes”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$49,703,204
- Xinhua Li · Nano Terra, Inc.$36,065,022
- Jennifer Marie Suga · Kaiser Foundation Research Institute$29,218,159
- Pamela Winer Goldberg · Medical Device Innovation Consortium$28,780,000
- Olwen Hahn · Brigham And Women'S Hospital$23,691,312
- Tareq Al Baghdadi · Saint Joseph Mercy Health System$16,009,505
Research focus
Patient-Focused OutcomesTumorMalignant Breast NeoplasmNeoplasm MetastasisResponseTranscription FactorGeneticIn VivoMetastatic Breast CancerMouse ModelPublishingBreast Cancer PatientSmall Molecule InhibitorTherapeutic TargetCessation Of LifeChemotherapyBreast Cancer CellHeat-Shock Factor 1Mammary NeoplasmsMediatingMolecularCell PhysiologyCellsTumor Growth
Grant awards (4)
Targeting heat shock factor 1 (HSF1) to increase tumor infiltrating lymphocytes in metastatic breast cancer.$378,444
R01 · FY2025 · CA · contact PI
Functional interactions between AKT and HSF-1 in breast cancer progression$162,000
K22 · FY2019 · CA · contact PI
Functional interactions between AKT and HSF-1 in breast cancer progression$162,000
K22 · FY2018 · CA · contact PI
Functional interactions between AKT and HSF-1 in breast cancer progression$162,000
K22 · FY2017 · CA · contact PI